Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-18, Stock:JNJ, The news for the past five days is as follows:
2018-04-11: NEWS1: J&J, Imerys unit must pay $117 million in New Jersey asbestos cancer case.NEWS2: J&J, Imerys unit must pay $117 mln in N.J. asbestos cancer case.NEWS3: Novartis’s Valuation and Analysts’ Recommendations on April 11.NEWS4: Asbestos in Talc Products Verdict Means J&J, Imerys Owe Millions.NEWS5: J&J, Imerys must pay $80 mln punitive damages in case linking cancer to asbestos in talc.NEWS6: Novartis’s Stock Performance following the AveXis Agreement.NEWS7: Karyopharm's Myeloma Candidate Gets Fast Track Designation.NEWS8: Karyopharm's Myeloma Candidate Gets Fast Track Designation.NEWS9: Dow Analyst Moves: JNJ.NEWS10: Dow Analyst Moves: JNJ.NEWS11: 4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings.NEWS12: 4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings.NEWS13: Alkermes Has Some Decisions to Make.NEWS14: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2018.NEWS15: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2018.NEWS16: 4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings.NEWS17: How GlaxoSmithKline Stock Performed in 1Q18.NEWS18: [$$] Healthcare: Cancer breakthrough leads China’s biotech boom.
2018-04-12: NEWS1: U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report.NEWS2: Top ETF Picks for Your IRA.NEWS3: Top ETF Picks for Your IRA.NEWS4: Why Geron Corporation Stock Is on the Rise Today.NEWS5: Why Geron Corporation Stock Is on the Rise Today.NEWS6: Top ETF Picks for Your IRA.NEWS7: A Look at Johnson & Johnson’s Darzalex.NEWS8: Why Geron Corporation Stock Is on the Rise Today.NEWS9: Get a look at Johnson & Johnson&apos;s HQ expansion in Lake Nona (RENDERINGS).NEWS10: J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store?.NEWS11: J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store?.NEWS12: J&J (JNJ) to Begin Pharma Q1 Earnings: What&apos;s in Store?.NEWS13: Ad Prices On Fox's 'The Ingraham Angle' Fall In The Wake Of Advertiser Boycott.NEWS14: Ad Prices On Fox's The Ingraham Angle Fall In The Wake Of Advertiser Boycott.NEWS15: Ad Prices On Fox's "Ingraham Angle" Fall In The Wake Of Advertiser Boycott.
2018-04-13: NEWS1: Local experts talks artificial intelligence on the First Coast.NEWS2: Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings?.NEWS3: Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings?.NEWS4: Here's Why Geron Stock Surged More Than 90% in 6 Months.NEWS5: Here's Why Geron Stock Surged More Than 90% in 6 Months.NEWS6: Stocks Close Mostly Lower After Seeing Initial Strength - U.S. Commentary.NEWS7: Stocks Close Mostly Lower After Seeing Initial Strength - U.S. Commentary.NEWS8: Here&apos;s Why Geron Stock Surged More Than 90% in 6 Months.NEWS9: Is J&J&apos;s (JNJ) Pharma Segment Likely to Drive Q1 Earnings?.NEWS10: Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson.NEWS11: With A -92.14% Earnings Drop, Did Johnson & Johnson (NYSE:JNJ) Really Underperform?.NEWS12: Can Johnson & Johnson Get Its Mojo Back?.NEWS13: Can Johnson & Johnson Get Its Mojo Back?.NEWS14: Why Geron Corporation Stock Popped 84% in March.NEWS15: Why Geron Corporation Stock Popped 84% in March.NEWS16: Can Johnson & Johnson Get Its Mojo Back?.NEWS17: Modest Weakness Remains Visible On Wall Street - U.S. Commentary.NEWS18: Modest Weakness Remains Visible On Wall Street - U.S. Commentary.NEWS19: Why Geron Corporation Stock Popped 84% in March.NEWS20: Stocks Turn Lower After Initial Move To The Upside - U.S. Commentary.NEWS21: Stocks Turn Lower After Initial Move To The Upside - U.S. Commentary.NEWS22: Stocks May Open Higher On Upbeat Earnings News - U.S. Commentary.NEWS23: Stocks May Open Higher On Upbeat Earnings News - U.S. Commentary.
2018-04-16: NEWS1: Fed speakers and earnings from Goldman Sachs and others could influence Tuesday's market.NEWS2: Noteworthy Monday Option Activity: CVNA, JNJ, TRN.NEWS3: Noteworthy Monday Option Activity: CVNA, JNJ, TRN.NEWS4: Pre-Market Earnings Report for April 17, 2018 :  JNJ, UNH, GS, PGR, PLD, NTRS, CMA, OMC, MLNX, MBWM.NEWS5: Pre-Market Earnings Report for April 17, 2018 :  JNJ, UNH, GS, PGR, PLD, NTRS, CMA, OMC, MLNX, MBWM.NEWS6: Pa., N.J. health systems and universities form multistate clinical trials consortium.NEWS7: Upadacitinib Could Drive AbbVie’s Long-Term Growth.NEWS8: Upcoming Earnings: Johnson & Johnson And IBM Are Scheduled To Report This Week.NEWS9: Stocks Close Notably Higher On Upbeat Earnings, Economic News - U.S. Commentary.NEWS10: Stocks Close Notably Higher On Upbeat Earnings, Economic News - U.S. Commentary.NEWS11: Dow Movers: DIS, MRK.NEWS12: Dow Movers: DIS, MRK.NEWS13: J&J Baby Powder litigation takes new focus with asbestos claims.NEWS14: Analysts’ Recommendations for Johnson & Johnson on April 16.NEWS15: Johnson & Johnson’s Revenue Estimates for 1Q18.NEWS16: What to Expect from Johnson & Johnson’s 1Q18 Earnings.NEWS17: Medtronic's Portfolio Is Unmatched.NEWS18: J&J Baby Powder litigation takes new focus with asbestos claims.NEWS19: J&J Baby Powder litigation takes new focus with asbestos claims.NEWS20: European Shares Seen Up As Markets Shrug Off Syria Strikes.NEWS21: European Shares Seen Up As Markets Shrug Off Syria Strikes.
2018-04-17: NEWS1: Trump touts economy as stocks rally.NEWS2: Sensex, Nifty Seen Up On Growth Optimism.NEWS3: Sensex, Nifty Seen Up On Growth Optimism.NEWS4: Thai Bourse May Find Renewed Support On Wednesday.NEWS5: Thai Bourse May Find Renewed Support On Wednesday.NEWS6: Indonesia Stock Market May Challenge Resistance At 6,300 Points.NEWS7: Indonesia Stock Market May Challenge Resistance At 6,300 Points.NEWS8: Hang Seng May Stop The Bleeding On Wednesday.NEWS9: Hang Seng May Stop The Bleeding On Wednesday.NEWS10: Johnson & Johnson Stock Dips Despite Q1 Earnings Beat.NEWS11: Johnson & Johnson Stock Dips Despite Q1 Earnings Beat.NEWS12: U.S. drug agency proposes rules to rein in opioid manufacturing.NEWS13: What to Look for as First-Quarter Earnings Hit Around the Globe.NEWS14: China Bourse May Find Traction On Wednesday.NEWS15: China Bourse May Find Traction On Wednesday.NEWS16: UnitedHealth and Alphabet climb; Tesla and Comerica skid.NEWS17: Wall Street rises on earnings hopes, Netflix soars.NEWS18: Health Care Sector Update for 04/17/2018: ARQL,NCVR,JNJ,CLVS.NEWS19: Health Care Sector Update for 04/17/2018: ARQL,NCVR,JNJ,CLVS.NEWS20: Taiwan Bourse May Snap Losing Streak.NEWS21: Taiwan Bourse May Snap Losing Streak.NEWS22: J&J Boosts Sales Forecast On Growing Demand For Cancer Drugs.NEWS23: Dow Jumps Over 200 Points; S&P 500 and Nasdaq Also Finish Higher.NEWS24: Singapore Market Draws Firm Lead For Wednesday.NEWS25: Singapore Market Draws Firm Lead For Wednesday.NEWS26: Win Streak May Continue For Malaysia Stocks.NEWS27: Win Streak May Continue For Malaysia Stocks.NEWS28: Johnson & Johnson (JNJ) Q1 2018 Earnings Conference Call Transcript.NEWS29: Johnson & Johnson (JNJ) Q1 2018 Earnings Conference Call Transcript.NEWS30: Dow Rises Sharply, Nasdaq Surges as Netflix Powers Higher.NEWS31: South Korea Shares May Reverse Tuesday's Losses.NEWS32: South Korea Shares May Reverse Tuesday's Losses.NEWS33: Why Geron Corporation's Stock Is Heading Higher Today.NEWS34: Why Geron Corporation's Stock Is Heading Higher Today.NEWS35: Health Care Sector Update for 04/17/2018: NVCR,JNJ,CLVS.NEWS36: Health Care Sector Update for 04/17/2018: NVCR,JNJ,CLVS.NEWS37: Mid-day Update: Earnings Steal Wall Street's Focus Away From Geopolitics, China.NEWS38: Mid-day Update: Earnings Steal Wall Street's Focus Away From Geopolitics, China.NEWS39: Bristol-Myers (BMY) Down as Merck NSCLC Study Fares Better.NEWS40: Bristol-Myers (BMY) Down as Merck NSCLC Study Fares Better.NEWS41: J&J raises sales forecast but keeps profit outlook unchanged; shares drop.NEWS42: Drug Division Drives Johnson & Johnson.NEWS43: Why Geron Corporation&apos;s Stock Is Heading Higher Today.NEWS44: Johnson & Johnson Stock Dips Despite Q1 Earnings Beat.NEWS45: Upbeat Earnings News Leads To Rally On Wall Street - U.S. Commentary.NEWS46: Upbeat Earnings News Leads To Rally On Wall Street - U.S. Commentary.NEWS47: J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance.NEWS48: J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance.NEWS49: Tax Day Not So Taxing (for Corporations, Housing).NEWS50: Tax Day Not So Taxing (for Corporations, Housing).NEWS51: New Construction Data, Q1 Earnings In Focus.NEWS52: New Construction Data, Q1 Earnings In Focus.NEWS53: Dow Movers: JNJ, UNH.NEWS54: Dow Movers: JNJ, UNH.NEWS55: Johnson & Johnson (JNJ) Q1 2018 Earnings Conference Call Transcript.NEWS56: J&J raises sales forecast but keeps profit outlook unchanged; shares drop.NEWS57: Zytiga, Stelara Lift Johnson & Johnson's Sales.NEWS58: Zytiga, Stelara Lift Johnson & Johnson's Sales.NEWS59: Morning Movers: Goldman, UnitedHealth Jump on Earnings, Twitter Takes Off on Upgrade.NEWS60: Morning Movers: Goldman, UnitedHealth Jump on Earnings, Twitter Takes Off on Upgrade.NEWS61: Novartis’s 1Q18: Analysts Expect Revenue Growth.NEWS62: Johnson & Johnson tops 1Q views on sales spike, but net dips.NEWS63: J&J Lives Up to Its Valuation -- For Now.NEWS64: New Construction Data, Q1 Earnings In Focus.NEWS65: Tax Day Not So Taxing (for Corporations, Housing).NEWS66: J&J (JNJ) Beats on Q1 Earnings & Sales, Ups 2018 Sales View.NEWS67: J&J (JNJ) Beats on Q1 Earnings & Sales, Ups 2018 Sales View.NEWS68: Dow Soars, Nasdaq Surges as Netflix Powers Higher.NEWS69: J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance.NEWS70: Zytiga, Stelara Lift Johnson & Johnson&apos;s Sales.NEWS71: Stocks Extend Rally as Goldman Sachs and Netflix Power Higher.NEWS72: Stocks to Watch: Goldman Sachs, Netflix, Amazon, Tesla, Microsoft, Roku, UnitedHealth, J&J, Walmart.NEWS73: Health Care Sector Update for 04/17/2018: JNJ, ARQL, AVXL, NVCR, CLVS.NEWS74: Health Care Sector Update for 04/17/2018: JNJ, ARQL, AVXL, NVCR, CLVS.NEWS75: Morning Movers: Goldman, UnitedHealth Jump on Earnings, Twitter Takes Off on Upgrade.NEWS76: J&J raises sales forecast on strong demand for cancer drugs.NEWS77: Premarket Trading: Blue Chips, Netflix Power Up; China Adds Tariffs.NEWS78: [$$] US stock futures higher as earning season picks up pace.NEWS79: Johnson & Johnson tops 1Q views on sales spike, but net dips.NEWS80: Why Johnson & Johnson’s (NYSE:JNJ) ROE Of 2.16% Does Not Tell The Whole Story.NEWS81: J&J (JNJ) Beats on Q1 Earnings & Sales, Ups 2018 Sales View.NEWS82: Stocks making the biggest moves premarket: UNH, JNJ, GS, NFLX, ROKU, DIS & more.NEWS83: Stocks Significantly Higher In Mid-Day Trading - U.S. Commentary.NEWS84: Stocks Significantly Higher In Mid-Day Trading - U.S. Commentary.NEWS85: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS86: European Markets Bounced Back As Geopolitical Concerns Ease.NEWS87: European Markets Bounced Back As Geopolitical Concerns Ease.NEWS88: Johnson & Johnson CFO Plans for a Strong Year for 2018.NEWS89: Johnson & Johnson CFO Plans for a Strong Year for 2018.NEWS90: Dominic Caruso Says Johnson & Johnson Is Still Planning for Strong 2018.NEWS91: Global stocks turn higher on upbeat corporate earnings.NEWS92: New Research: Key Drivers of Growth for Johnson & Johnson, Chesapeake Energy, Visa, Celgene, Adobe, and Markel — Factors of Influence, Major Initiatives and Sustained Production.NEWS93: [$$] Johnson & Johnson up in pre-market as Q1 results top forecasts.NEWS94: Earnings Reaction History: Johnson & Johnson, 72.7% Follow-Through Indicator, 2.4% Sensitive.NEWS95: Earnings Reaction History: Johnson & Johnson, 72.7% Follow-Through Indicator, 2.4% Sensitive.NEWS96: J&J Raises Sales Forecast in Health Earnings-Season Kickoff.NEWS97: Johnson & Johnson Earnings Beat Views; Sales Target Nudged Higher.NEWS98: Johnson & Johnson's stock gains after profit and revenue beat, raised outlook.NEWS99: Johnson & Johnson CFO: Pharma business continues 'stellar....NEWS100: Upbeat Earnings News Contributes To Strength On Wall Street - U.S. Commentary.NEWS101: Canadian Stocks Continue To Inch Higher - Canadian Commentary.NEWS102: Upbeat Earnings News Contributes To Strength On Wall Street - U.S. Commentary.NEWS103: Canadian Stocks Continue To Inch Higher - Canadian Commentary.NEWS104: Johnson & Johnson Reports 2018 First-Quarter Results:.NEWS105: Pharma fuels Johnson & Johnson's first-quarter earnings beat.NEWS106: Here&apos;s what to expect from Johnson & Johnson earnings.NEWS107: Johnson & Johnson to Host Earnings Call.NEWS108: Futures Pointing To Continued Strength On Wall Street - U.S. Commentary.NEWS109: Futures Pointing To Continued Strength On Wall Street - U.S. Commentary.NEWS110: Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions.NEWS111: Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions.NEWS112: Johnson & Johnson Q1 adjusted earnings Beat Estimates.NEWS113: Johnson & Johnson Q1 adjusted earnings Beat Estimates.NEWS114: 5 of the Best Big Cap Earnings Charts.NEWS115: 5 of the Best Big Cap Earnings Charts.

Answer: Decrease